Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Average Wholesale Pricing Economic Experts: Healthcare Consultants

Articles with lock require a subscription to GLG News | Request a free trial
Adam FeinNovember 13, 2008
CVS Escalates the Generic Price War
Analysis of: CVS joins generic drug price war | www.upi.com
Author: Adam Fein, Founder & President, Pembroke Consulting Inc
CVS Caremark (CVS) launched its new Health Savings Pass, which allows customers to buy 90 day supplies of over 400 generics for $9.99 (after paying an enrollment fee of $10). The new program sounds like a logical pre-emptive strike against anticipated share losses. Translation: an old-fashioned, race-to-the-bottom...
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
Analysis of: FDA Asks if Pain Pill Is Tamper-Proof | online.wsj.com
Author: David Zimmerman, President/Owner, Doctors of Pharmacy, Inc.
This drug will allow patients in severe pain to get the necessary pain relief and not have to worry about the other patients that abuse the drug.
Adam FeinNovember 6, 2008
New Details on WMT-CAT Pharmacy Deal
Analysis of: Caterpillar/Wal-Mart Rx Drug Pilot Scraps Use of Average Wholesale Price, Uses Drug Cost-Plus Pricing | www.aishealth.com
Author: Adam Fein, Founder & President, Pembroke Consulting Inc
A just-published article in Drug Benefit News provides new details about the Wal-Mart’s (WMT) $0 generic co-pay program with Caterpillar (CAT). Anyone involved in the pharmacy channel – pharmacies, pharmacy benefit managers (PBMs), insurers, payers, drug wholesalers – should be paying attention to the...
Adam FeinNovember 4, 2008
Walgreens buys McKesson Specialty Pharmacy: A Win-Win Deal
Analysis of: Walgreen Co. to Acquire Specialty Pharmacy Business from McKesson Corporation | news.walgreens.com
Author: Adam Fein, Founder & President, Pembroke Consulting Inc
Walgreens (WAG) announced the acquisition of McKesson’s (MCK) specialty pharmacy business in a win-win transaction for both companies. The deal makes sense for both parties as long you understand that specialty distributors sell products to physicians, providers and pharmacies, while specialty pharmacies...
Adam FeinNovember 4, 2008
Prescriptions and the Economy: Perhaps Not So Bad
Analysis of: In Sour Economy, Some Scale Back on Medications | www.nytimes.com
Author: Adam Fein, Founder & President, Pembroke Consulting Inc
The New York Times ran a story on the impact of the economy on prescriptions. The article provided many compelling personal stories to illustrate data from IMS Health showing a decline in the total number of prescriptions dispensed in the United States. However, I have some concerns about the ability...
Adam FeinOctober 14, 2008
Dangers of Rogue Online Pharmacies
Analysis of: Online Overdose | columbusdispatch.com
Author: Adam Fein, Founder & President, Pembroke Consulting Inc
The Columbus Dispatch published a six-part expose/overview about the diversion and sale of controlled substances. Mike Pramik, the reporter who wrote all six parts, has pulled together a must-read series. Since the Dispatch is also Cardinal Health’s (CAH) hometown paper, there are some good insights...
Adam FeinOctober 9, 2008
Cardinal Health Finally Resolves DEA Issue
Analysis of: Cardinal Health Resolves Controlled Substance License Suspensions | ir.cardinalhealth.com
Author: Adam Fein, Founder & President, Pembroke Consulting Inc
Last week, Cardinal Health (CAH) announced agreements with the Drug Enforcement Adminstration (DEA) regarding its license suspensions for controlled substances. These suspensions had a negative impact on the company's sales and market position. The company even publicly apologized for its actions during...
Adam FeinOctober 6, 2008
Cardinal Health Invests in China
Analysis of: Pharmaceutical distribution at the heart of Cardinal Health's China strategy | www.interfax.com
Author: Adam Fein, Founder & President, Pembroke Consulting Inc
Cardinal Health (CAH) is rapidly growing its Chinese drug distribution business, while expanding manufacturing in India (but not China). This strategy is especially interesting given Cardinal’s planned separation of its supply chain division from clinical & medical products. The era of global wholesalers...
Adam FeinOctober 2, 2008
Wal-Mart + Caterpillar: The Future of PBM & Pharmacy?
Analysis of: Caterpillar in prescription drug trial with Wal-Mart | in.reuters.com
Author: Adam Fein, Founder & President, Pembroke Consulting Inc
Wal-Mart Stores (WMT) announced an innovative new program with Caterpillar (CAT) that provides $0 co-pays on 2,500 generic drugs for 70,000 beneficiaries (employees, retirees, spouses, dependents). As I see it, the deal does not represent a direct frontal assault on PBMs such as Express Scripts (ESRX)...
Adam FeinSeptember 16, 2008
Wholesaler Impact of a Longs Drug Deal
Analysis of: Walgreen Jumps In With Rival Bid for Longs Drug | online.wsj.com
Author: Adam Fein, Founder & President, Pembroke Consulting Inc
Walgreens (NYSE:WAG) and CVS Caremark (NYSE:CVS) are now in a bidding war for Longs Drug Stores (NYSE:LDG). No matter which company wins, the long-term outcome will probably be negative for AmerisourceBergen (NYSE:ABC), which is Longs’ primary wholesale supplier.  The sale of Longs Drug Stores...

Page : 1 2 3 4 5 6 7 8 9 10 Next1 to 10 of 152

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T09:45:16.773